Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Muping Di"'
Autor:
Muping Di, Jingjing Miao, Qiuzhong Pan, Zonglong Wu, Boyu Chen, Muru Wang, Jingjing Zhao, Huageng Huang, Jiewen Bai, Qijing Wang, Yan Tang, Yongqiang Li, Jia He, Tong Xiang, Desheng Weng, Lin Wang, Jianchuan Xia, Chong Zhao
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-18 (2022)
Abstract Background Radioresistance is the primary cause of nasopharyngeal carcinoma (NPC) treatment failure. Previous studies have focused on the deficits in cellular apoptosis as a mechanism for radioresistance; however, additional potential death
Externí odkaz:
https://doaj.org/article/8bde339aeb264cb48762afe6ff149162
Autor:
Jieying Yang, Zhixing Guo, Mengjia Song, Qiuzhong Pan, Jingjing Zhao, Yue Huang, Yulong Han, Dijun Ouyang, Chaopin Yang, Hao Chen, Muping Di, Yan Tang, Qian Zhu, Qijing Wang, Yongqiang Li, Jia He, Desheng Weng, Tong Xiang, JianChuan Xia
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionThe limited response to immune checkpoint blockades (ICBs) in patients with hepatocellular carcinoma (HCC) highlights the urgent need for broadening the scope of current immunotherapy approaches. Lenvatinib has been shown a potential syne
Externí odkaz:
https://doaj.org/article/207e3cc2570549e2ad4638ce40e5d928
Autor:
Muping Di, Meng Wang, Jingjing Miao, Boyu Chen, Huageng Huang, Chuyong Lin, Yunting Jian, Yue Li, Ying Ouyang, Xiangfu Chen, Lin Wang, Chong Zhao
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 123, Iss , Pp 109748- (2020)
Background: Radiotherapy is the main treatment for nasopharyngeal carcinoma (NPC); however radioresistance restricts its efficacy. Therefore, new molecular regulators are required to improve the radiosensitivity of NPC. Chromatin assembly factor 1 su
Externí odkaz:
https://doaj.org/article/33c14b54de854e658bc85aff9b0e441a
Autor:
Mengjia Song, Jieying Yang, Muping Di, Ye Hong, Qiuzhong Pan, Yufei Du, Tong Xiang, Juan Liu, Yan Tang, Qijing Wang, Yongqiang Li, Jia He, Hao Chen, Jingjing Zhao, Desheng Weng, Yizhuo Zhang, Jian-Chuan Xia
Publikováno v:
Theranostics. 13:1649-1668
Autor:
Fei Han, Kah Hie Wong, Wei-Xiong Xia, Jingjing Miao, Xiang Guo, Yan-Qing Cao, Yan-Qun Xiang, Joseph Wee, Huageng Huang, Weiwei Xiao, Melvin L.K. Chua, Chong Zhao, Boyu Chen, Shaomin Huang, Xiaowu Deng, Muping Di, Luo Huang, Xing Lv, Lin Wang, Manyi Zhu, Sze Huey Tan
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 107:672-682
Purpose Current guideline recommends a uniform method of delineation of subclinical disease within the primary clinical target volume (CTVp) for all stages of nasopharyngeal carcinoma (NPC). We performed a prospective observational study to investiga
Publikováno v:
Annals of Blood. 7:32-32
Autor:
Chong Zhao, Lin Wang, Xiaowu Deng, Muping Di, Jingjing Miao, Fei Han, Weiwei Xiao, Manyi Zhu, Xiang Guo, Haijun Wu, Yuqing Huang, Shaomin Huang
Publikováno v:
Oral Oncology. 90:126-133
Background To analyse the survival and late toxicities of elderly nasopharyngeal carcinoma (NPC) patients treated by intensity-modulated radiotherapy (IMRT) with the high-total- and fractionated-dose simultaneous modulated accelerated radiation thera
Autor:
Jingjing Miao, Lin Wang, Manyi Zhu, Weiwei Xiao, Haijun Wu, Muping Di, Yuqing Huang, Shaomin Huang, Fei Han, Xiaowu Deng, Xiang Guo, Chong Zhao
Publikováno v:
Oral Oncology. 89:40-47
Autor:
Yunting Jian, Jingjing Miao, Meng Wang, Chong Zhao, Huageng Huang, Lin Wang, Muping Di, Xiangfu Chen, Yue Li, Chuyong Lin, Boyu Chen, Ying Ouyang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 123, Iss, Pp 109748-(2020)
Background Radiotherapy is the main treatment for nasopharyngeal carcinoma (NPC); however radioresistance restricts its efficacy. Therefore, new molecular regulators are required to improve the radiosensitivity of NPC. Chromatin assembly factor 1 sub
Autor:
Chong Zhao, Hai-Qiang Mai, Muping Di, Huageng Huang, Boyu Chen, Jingjing Miao, Manyi Zhu, Haijun Wu, Lin Wang
Publikováno v:
Oral Oncology. 120:105378
Objective The aim of this study was to establish a nomogram for predicting radiation-induced hypothyroidism (RHT) based on an equivalent dose at 2 Gy per fraction (EQD2) in patients with nasopharyngeal carcinoma (NPC) treated with intensity-modulated